Research & Development
8 July 2020 - - LYNPARZA has been approved in the European Union as a monotherapy for the maintenance treatment of adult patients with germline BRCA1/2 mutations who have metastatic adenocarcinom...
8 July 2020 - - The US Food and Drug Administration has approved US-based biotechnology company Talaris Therapeutics, Inc's Investigational New Drug application for the evaluation of Talaris'...
8 July 2020 - - US-based Ridgeback Biotherapeutics has started enrollment in a Phase 2 trial of potential COVID-19 treatment EIDD-2801, the company said.

The new trial will be conducted u...
8 July 2020 - - US-based biotechnology company Moderna, Inc., (NASDAQ: MRNA), which is developing messenger RNA therapeutics and vaccines, has completed enrollment for both cohorts of the Phase 2 stud...
8 July 2020 - Medical company Soterix Medical Inc reported on Tuesday the receipt of the US FDA Investigational Device Exception (IDE) to commence the trial of transcranial Direct Current Stimulation-...
8 July 2020 - Astex Pharmaceuticals Inc, a subsidiary of Otsuka Pharmaceutical Co Ltd, has received approval from the United States Food and Drug Administration (FDA) for its Inqovi (decitabine and ce...
Related Headlines